Details for 2017828540
Up to date per 07.04.2026
Actions
Details for 2017828540
Granted/Registered
European Patent
19.06.2019 A
28.04.2021 B1
15.07.2016
US
201662362955 P
02.02.2017
US
201762453888 P
24.05.2017
US
201762510403 P
A61K 38/17 20060101AFI20200225BHEP
Owner
Acceleron Pharma Inc.126 East Lincoln Avenue Rahway, New Jersey 07065US
Representative
No representatives present
Inventor
KUMAR, Ravindra421 Arlington Street Acton MA 01720US
KNOPF, John147 Robbins Drive Carlisle MA 01741US
Information about Fees